Skip to main content
Premium Trial:

Request an Annual Quote

Iris BioTechnologies

Premium
Iris BioTechnologies this week launched BioWindows, a computer-based survey program designed for individuals to compile personalized in-depth profiles to help determine the most appropriate medical solution for cancer treatment.
 
According to Iris, each individual that uses BioWindows confidentially enters personal information, including demographics, medical history, and lifestyle choices, into a database. The information obtained in the survey is then used alongside gene expression profiles of tumor biopsy samples obtained with Iris’ Nano-BioChip to tailor treatment for the individual.
 
BioArray News spoke with Iris CEO Simon Chin about BioWindows in March (see BAN 3/11/2008).

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.